Search clinical trials for: Foster® 100/6 µg/unit dose
Total 131 results
-
Chiesi Farmaceutici S.p.A.TerminatedChronic Obstructive Pulmonary DiseaseNetherlands
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseItaly
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
INSYS Therapeutics IncWithdrawn
-
Chiesi Farmaceutici S.p.A.Completed
-
Orion Corporation, Orion PharmaCompleted
-
Children's Hospital Medical Center, CincinnatiExThera Medical CorporationEnrolling by invitationCOVID-19 | SARS-CoV 2United States
-
University Hospital, Gentofte, CopenhagenB. Braun Melsungen AGCompletedIntermittent Claudication | Critical Limb Ischemia
-
MedicagoCompletedRNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract DiseasesUnited States, Canada
-
Chiesi Farmaceutici S.p.A.CompletedAsthmaBulgaria, Germany, Hungary, Italy, Poland, United Kingdom
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaUnited States, Israel, Canada, Singapore, Philippines, Spain, Australia, Belgium, Brazil, Germany
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseChina
-
Chiesi Farmaceutici S.p.A.Completed
-
Bial - Portela C S.A.Completed
-
Eli Lilly and CompanyCompleted
-
Statens Serum InstitutBill and Melinda Gates Foundation; Aurum Institute; Leiden University Medical... and other collaboratorsRecruiting
-
Seoul National UniversityCompletedKnee Pain Intermittent
-
Chiesi Farmaceutici S.p.A.SGS S.A.Recruiting
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseFrance
-
Orion Corporation, Orion PharmaCompleted
-
Chiesi ItaliaActive, not recruiting
-
NYU Langone HealthRecruiting
-
Hoffmann-La RocheActive, not recruitingSolid Tumors | CNS TumorsUnited States, Spain, Korea, Republic of, Canada, Germany, United Kingdom, China, Italy, Hong Kong, France, Taiwan
-
Medical College of WisconsinBarbara Ann Karmanos Cancer Institute; Cornerstone PharmaceuticalsRecruitingPancreas AdenocarcinomaUnited States
-
MAXVAX Biotechnology Limited Liability CompanyHenan Center for Disease Control and PreventionActive, not recruiting
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
Instituto Nacional de Salud Publica, MexicoNational Council of Science and Technology, Mexico; Universidad Nacional Autonoma...Completed
-
Rajavithi HospitalCompleted
-
AllerganCompletedRetinitis PigmentosaFrance, United States, Germany, Portugal
-
MAXVAX Biotechnology Limited Liability CompanyHenan Center for Disease Control and PreventionActive, not recruiting
-
Federal Budgetary Research Institution State Research...CompletedSmallpox | Monkeypox | Cowpox | Vaccinia Virus InfectionRussian Federation
-
University Hospital, AntwerpChiesi Farmaceutici S.p.A.Completed
-
PfizerRecruitingHealthy ParticipantsUnited States
-
Duke UniversityJohns Hopkins University; Centers for Disease Control and PreventionCompletedQuality of Life | Pain | Adverse Drug Event | Injection Site ReactionUnited States
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; ModernaTX, Inc.CompletedImmunocompromised PatientsSwitzerland
-
University of ReadingINNOPURENot yet recruitingAutismUnited Kingdom
-
Forest LaboratoriesCompletedCystic Fibrosis | Exocrine Pancreatic InsufficiencyUnited States
-
Bial - Portela C S.A.CompletedParkinson DiseasePortugal
-
Organon and CoCompleted
-
Chiesi Farmaceutici S.p.A.CompletedCOPD (Chronic Obstructive Pulmonary Disease)China, Korea, Republic of, Taiwan
-
Tris Pharma, Inc.CompletedDiabetes Mellitus | Diabetic Neuropathies | Chronic PainFrance, Spain, Austria, United States, Denmark, Germany, Italy, Netherlands
-
Research in Real-Life LtdChiesi Farmaceutici S.p.A.Completed
-
Actavis Inc.Completed
-
Actavis Inc.Completed
-
Research in Real-Life LtdChiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseItaly, Germany, Hungary